CompuMed to Provide CardioGramKids and CompuBridge e-Health Services to Operation Samahan Community Clinics and School Health Ce
October 28 2010 - 8:00AM
CompuMed, Inc. (OTCBB:CMPD)
(http://www.compumed.net), a
telemedicine and
medical informatics company, has entered into an
agreement with Operation Samahan (http://www.operationsamahan.org)
to provide CompuMed's
CardioGramKids®
electrocardiogram (ECG) telemedicine and
CompuBridge™ electronic health record (EHR) services system wide to
Operation Samahan's five community clinics and school health
centers.
Operation Samahan operates one of the nation's leading community
clinic organizations, providing San Diego County residents with
nearly 50,000 patient visits per year at five community clinics and
school health centers.
CompuMed's CardioGramKids Pediatric Screening Program provides
ECG screening services to children and teenagers prior to taking
psychotropic medications or participating in school or afterschool
sports programs. CompuMed's CompuBridge service enables real-time
integration of ECG and other data into a wide variety of EHR
systems.
"We are very excited to partner with Operation Samahan to
enhance the delivery of preventive medicine in San Diego County,"
said CEO Maurizio Vecchione. "With the extension of our school
health center program into community clinics and our integration of
ECG and EHR technologies, CompuMed remains at the forefront of ECG
telemedicine. We are also well positioned to assist healthcare
providers everywhere in making meaningful use of electronic health
records technology in a way that is at once powerful and
practical," Mr. Vecchione added.
CompuMed will provide Operation Samahan with the company's
CardioGramKids ECG equipment and with over-reads performed remotely
by CompuMed's pediatric cardiologists. CompuMed will also work
with Operation Samahan to enable real-time integration of ECG
results into their system wide EHR programs. ECG data combined
with other personal diagnostic or treatment data in EHR systems can
help alert physicians to a variety of significant health issues,
including the cardiac impact of prescribed medications and other
treatment regimens.
"We are very grateful to CompuMed for enabling us to provide our
community clinic patients and local school children with state of
the art ECG and EHR services that are both convenient and
affordable," said Joel San Juan, CEO and Executive Director of
Operation Samahan.
"The ability to access pediatric cardiologist overreads and
integrate ECG and EHR data in such a practical manner greatly
increases the range and scope of what we are able to provide here
at the clinical level," said Operation Samahan Medical Director
Maria T. Villa, M.D. "Our system wide deployment of CompuMed
technology has the potential to result in a significant long-term
reduction of morbidity and mortality associated with previously
unrecognized cardiac conditions in our county's youth, particularly
among the population we serve who may formerly have had limited
access to such sophisticated services," added Dr. Villa.
For more information, visit CompuMed at http://www.compumed.net
and follow at Twitter: @compumed.
About CompuMed
CompuMed, Inc. (OTCBB:CMPD) develops and markets products and
services that combine advanced imaging with medical informatics.
Its focus is on analysis and remote monitoring for patients with
cardiovascular and musculoskeletal diseases. The company has
specialized expertise and intellectual property in telemonitoring
imaging and analysis designed to improve healthcare provider
workflow and patient care while reducing costs. CompuMed is
headquartered in Los Angeles and distributes its products worldwide
both directly and through OEM partners.
Forward Looking Statements
Statements contained in this press release that are not
historical facts, such as statements about prospective earnings,
savings, revenue, operations, revenue and earnings growth, results
of contracts and other financial results, are forward-looking
statements pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. All such forward-looking
statements including statements concerning the Company's plans,
objectives, expectations and intentions are based largely on
management's expectations and are subject to and qualified by risks
and uncertainties that could cause actual results to differ
materially from those expressed or implied by such statements.
These statements are subject to uncertainties and risks including,
without limitation, competitive factors, outsourcing trends in the
pharmaceutical industry, product and service demand and acceptance,
changes in technology, ability to raise capital, the availability
of appropriate acquisition candidates and/or business partnerships,
economic conditions, the impact of competition and pricing,
capacity and supply constraints or difficulties, government
regulation and other risks identified in the Company's filings with
the Securities and Exchange Commission including its Annual Report
on Form 10-KSB and Quarterly Reports on Form 10-QSB. All such
forward-looking statements are expressly qualified by these
cautionary statements. The Company expressly disclaims any
obligation or undertaking to release publicly any updates or
revisions to any forward-looking statements to reflect events,
conditions or circumstances on which any such statement is based
after the date hereof, except as required by law.
CONTACT: Tellem Worldwide
Susan Tellem
+1 310-313-3444
stellem@tellem.com
Common Stock (PK) (USOTC:CMPD)
Historical Stock Chart
From Sep 2024 to Oct 2024
Common Stock (PK) (USOTC:CMPD)
Historical Stock Chart
From Oct 2023 to Oct 2024